Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...
Enlicitide, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions Compared to Oral Non ...
Neumora Therapeutics is downgraded from 'Strong Buy' to 'Hold' following KOASTAL-1's failure in the MDD primary endpoint.
Nutshell reports that CRM customization is crucial for aligning tools with business processes, enhancing user experience, and improving data quality, ultimately driving success.
The addition of pembrolizumab to neoadjuvant chemotherapy followed by single-agent adjuvant pembrolizumab improved long-term ...
Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.
This high dose nusinersen regimen for spinal muscular atrophy includes 50mg loading doses and 28mg maintenance doses.
Hometap reports the true costs of buying and selling a home often exceed expectations, highlighting fees like down payments, ...
Agentic AI introduces new security risks. Learn how the OWASP Top 10 Risks for Agentic Applications maps to real mitigations ...
Unique in its focus on adolescents, the trial shows the cardiac myosin inhibitor safely reduces LVOT in the pediatric ...
Rademikibart administered as a single 300 mg 2-minute IV push to asthma and chronic obstructive pulmonary disease (COPD) patients produced rapid improvement in FEV1 with many patients experiencing imp ...
The individual populations of Lackawanna, Luzerne, Pike, Schuylkill and Wayne counties grew overall between 2020 and 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results